Clinical Trial Update: Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating citicoline for traumatic brain injury (COBRIT) was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Traumatic Brain Injury | Phase 3 | Status: TERMINATED | Results posted: 2012-12-19